NRx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| B GROUP, INC. | 11/14/2025 | 3.00 M | $4.46 M | 100.00% | 16.73% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 42.17 K | $3.37 K | 100.00% | 0.24% |
| WOLVERINE ASSET MANAGEMENT LLC | 10/28/2025 | 21.78 K | $1.55 K | 0.00% | 0.12% |
| UBS GROUP AG | 11/13/2025 | 18 | $1 | -98.80% | 0.00% |
| TRUIST FINANCIAL CORP | 11/03/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NRx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of NRx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
B Group, Inc.: 3 M
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 42,167
WOLVERINE ASSET MANAGEMENT LLC: 21,778
UBS Group AG: 18
TRUIST FINANCIAL CORP: 0
17.08% of NRx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.06 M shares in the last 24 months. This purchase volume represents approximately $444.27 K in transactions.